Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation
出版年份 2023 全文链接
标题
Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation
作者
关键词
-
出版物
Journal of Chemical Information and Modeling
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2023-11-01
DOI
10.1021/acs.jcim.3c01090
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exploration of Flavonoids as Lead Compounds against Ewing Sarcoma through Molecular Docking, Pharmacogenomics Analysis, and Molecular Dynamics Simulations
- (2023) Muhammad Yasir et al. MOLECULES
- Selectivity and Ranking of Tight-Binding JAK-STAT Inhibitors Using Markovian Milestoning with Voronoi Tessellations
- (2023) Anupam Anand Ojha et al. Journal of Chemical Information and Modeling
- Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor
- (2022) Jigar Desai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies
- (2022) Mubashir Hassan et al. ACS Omega
- Machine Learning in Drug Discovery: A Review
- (2021) Suresh Dara et al. ARTIFICIAL INTELLIGENCE REVIEW
- Janus kinase–signal transducers and activators of transcription cell signaling in Spondyloarthritis: rationale and evidence for JAK inhibition
- (2021) Suravi Raychaudhuri et al. CURRENT OPINION IN RHEUMATOLOGY
- Machine Learning: New Ideas and Tools in Environmental Science and Engineering
- (2021) Shifa Zhong et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Recent Developments in Free Energy Calculations for Drug Discovery
- (2021) Edward King et al. Frontiers in Molecular Biosciences
- JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016–present)
- (2021) Chengjuan Chen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS
- (2021) Mario S. Valdés-Tresanco et al. Journal of Chemical Theory and Computation
- Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases
- (2020) Kamonpan Sanachai et al. ACS Omega
- Drug repositioning: a brief overview
- (2020) Jean‐Pierre Jourdan et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Structure-Based Virtual Screening: From Classical to Artificial Intelligence
- (2020) Eduardo Habib Bechelane Maia et al. Frontiers in Chemistry
- Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
- (2020) Linlin Zhao et al. DRUG DISCOVERY TODAY
- In silico screening of GABA aminotransferase inhibitors from the constituents of Valeriana officinalis by molecular docking and molecular dynamics simulation study
- (2020) Jin-Young Park et al. JOURNAL OF MOLECULAR MODELING
- JAK2-mediated intracellular signaling
- (2020) Mentor Sopjani et al. CURRENT MOLECULAR MEDICINE
- Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms
- (2019) Min Hu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Drug repurposing: a promising tool to accelerate the drug discovery process
- (2019) Vineela Parvathaneni et al. DRUG DISCOVERY TODAY
- Artificial intelligence: Implications for the future of work
- (2019) John Howard AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
- (2019) Perner et al. Cells
- Survey of Machine Learning Techniques in Drug Discovery
- (2018) Natalie Stephenson et al. CURRENT DRUG METABOLISM
- Exploration of synthetic multifunctional amides as new therapeutic agents for Alzheimer's disease through enzyme inhibition, chemoinformatic properties, molecular docking and dynamic simulation insights
- (2018) Mubashir Hassan et al. JOURNAL OF THEORETICAL BIOLOGY
- Deep reinforcement learning for de novo drug design
- (2018) Mariya Popova et al. Science Advances
- JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation
- (2018) Julia Czech et al. LEUKEMIA
- A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions
- (2018) Tony Eight Lin et al. Frontiers in Pharmacology
- The ChEMBL database in 2017
- (2016) Anna Gaulton et al. NUCLEIC ACIDS RESEARCH
- Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities
- (2015) Elisabeth Losdyck et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Machine learning: Trends, perspectives, and prospects
- (2015) M. I. Jordan et al. SCIENCE
- Narrative Review: Thrombocytosis, Polycythemia Vera, and JAK2 Mutations: The Phenotypic Mimicry of Chronic Myeloproliferation
- (2013) Jerry L. Spivak ANNALS OF INTERNAL MEDICINE
- The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders
- (2013) Yasuko Furumoto et al. BIODRUGS
- CHARMM-GUI: A web-based graphical user interface for CHARMM
- (2008) Sunhwan Jo et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started